Ontario Welcomes Major Investment to Strengthen Home-Grown Manufacturing Capabilities

May 4, 2023

Our government has secured a multi-million-dollar investment from Moderna Inc. to expand vaccine manufacturing and provide Ontarians with faster, more reliable access to life-saving vaccines.

Not only will this investment create good paying jobs, it will provide our health care workers and people with more reliable access to life-saving vaccines, helping to ensure we no longer have to rely on other jurisdictions to keep us safe.

Through the Ontario Together Fund, we continue to grow our life sciences sector and help Ontario businesses innovate and bring their ideas to market.

Moderna is partnering with Novocol Pharma to add a new manufacturing line in their Cambridge facility that will complete the final steps of preparing and packaging a wide range of mRNA vaccines for distribution in Ontario and throughout Canada. This new partnership between Moderna and Novocol Pharma will create good paying jobs for the Cambridge community and help shore up our domestic production of vaccines to ensure faster access in the event of a future public health challenge.

Ontario continues to attract investments and jobs from companies around the world. Over the past two years, Ontario has attracted nearly $3 billion in investments by global biomanufacturers including Sanofi, AstraZeneca and Roche Pharmaceuticals.

Learn more: https://news.ontario.ca/en/release/1003012/ontario-welcomes-major-investment-to-manufacture-more-vaccines